Breakthroughs in the medical and biotechnology fields are coming at a rapid pace, but in order to complete the development of new drugs that can be used by humans, not only do we need to be more rigorous and careful, but the challenges and hurdles we face along the way are even more time-consuming, and the relevant regulations are also cumbersome and complex. However,
Chengjiao Biotech in Taiwan is working
tirelessly to make breakthroughs from a scientific perspective, hoping to find new drugs to fight cancer and enhance human immunity through research. Such an ideal is not unattainable, but is already visible. Present progressive tense.
The Chengjiao Biotech team is composed
of a number of scientists and Ph.D.s, creating a strong new drug research and development team.
All waste has value! Gold treatment may reverse terminal illness
Chengjiao Biotechnology has observed a very important phenomenon, that is, for ordinary people or disease patients, if the body wants to be healthy and the disease needs to be bc data china recovered, the immune system must be improved. 70% of the human body’s immune response occurs in the digestive tract. Therefore, we want to find a way to use intestinal bacteria to activate the immune response in the body. This will increase the possibility of attacking cancer cells and increase the therapeutic effect of cancer patients.
Zhiming, CEO of Chengjiao Biotechnology
also shared with us, “This idea also comes from past how to avoid many last-minute registrations for your event? [5 … experience in the research and development of new cancer drugs and foreign trends.” Many foreign biotechnology companies have established research topics related to intestinal bacteria. , although the progress is very early, major international qatar data pharmaceutical companies have completed many licensing cooperation cases, and around 2018, the licensing funds have reached 5 to 6 billion US dollars. Last year, the U.S. FDA approved two fecal bacteria drugs, confirming that feces can be regarded as a complex but effective therapeutic material. Chengjiao Biotech also saw opportunities for intestinal bacteria to treat diseases.
